Venetoclax or Ruxolitinib in Pre-Transplant Conditioning Lowers the Engraftment Barrier by Different Mechanisms in Allogeneic Stem Cell Transplant Recipients

Allogeneic stem cell transplantation (alloSCT) is utilised to cure haematological malignancies through a combination of conditioning regimen intensity and immunological disease control via the graft versus tumour (GVT) effect. Currently, conventional myeloablative chemotherapeutic or chemoradiation...

Descripción completa

Detalles Bibliográficos
Autores principales: Davis, Joanne E., Du, Kelei, Ludford-Menting, Mandy J., Prabahran, Ashvind, Wong, Eric, Huntington, Nicholas D., Koldej, Rachel M., Ritchie, David S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Immunology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498041/
https://www.ncbi.nlm.nih.gov/pubmed/34630428
http://dx.doi.org/10.3389/fimmu.2021.749094

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8498041/
https://www.ncbi.nlm.nih.gov/pubmed/34630428
http://dx.doi.org/10.3389/fimmu.2021.749094

Ejemplares similares